Action 300119 TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Tianjin Ringpu Bio-Technology Co.,Ltd.

Actions

300119

CNE100000TV1

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 08/05/2024 		Varia. 5j. Varia. 1 janv.
17,99 CNY +5,70 % Graphique intraday de Tianjin Ringpu Bio-Technology Co.,Ltd. +9,76 % +9,76 %
29/04 Tianjin Ringpu Bio-Technology Co. (SZSE:300119) a conclu l'acquisition de Baoding Shoujun Technology Co. auprès de Yao Lili, Zhang Xiaoqin et Tianjin Ruichuang Biotechnology Partnership (Limited Partnership). CI
25/04 Tianjin Ringpu Bio-Technology Co. publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Tianjin Ringpu Bio-Technology Co.,Ltd. completed the acquisition of Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership).
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on October 27, 2023, has closed with 3,689,608 shares, representing 0.8% for CNY 59.99 million.
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023.
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 80 million worth of its shares.
Tianjin Ringpu Bio-Technology Co.,Ltd. authorizes a Buyback Plan.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for 2022
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022
Tianjin Ringpu Bio-Technology Co.,Ltd. signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million.
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300119
  4. Actualités Tianjin Ringpu Bio-Technology Co.,Ltd.
  5. Autres langues